Publication: 3169

Prognostic Variables in Low and High Risk Stage III Colon Cancers Treated in Two Adjuvant Chemotherapy Trials
      QxMD      Google Scholar   
Citation:
Eur J Cancer vol 144 101-112
Year:
2021
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
10
Parents:
3083  
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
GI    
Pharmas:
Bristol Meyers Squibb, Pfizer, and Sanofi.  
Grants:
U10CA180821, U10CA180882, U24CA196171, UG1CA232760, R01 CA210509-01A1  
Corr. Author:
 
Authors:
                               
Networks:
LAPS-MN026, LAPS-OH007, LAPS-WI013   
Study
NCCTG-N0147
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Colon cancer, stage III, adjuvant therapy, risk groups, microsatellite instability, deficient mismatch repair, prognosis, recurrence